Literature DB >> 18218038

The effects of RANTES/CCR5 promoter polymorphisms on HIV disease progression in HIV-infected Koreans.

D H Jang1, B-S Choi, S S Kim.   

Abstract

Recent studies have reported that two single nucleotide polymorphisms (SNPs) in the RANTES gene promoter region, -403G/A and -28C/G, are associated with a slower rate of decline in CD4(+) T-cell number, whereas genetic polymorphisms within the CCR5 promoter are linked to acceleration of AIDS progression. In this study, we investigated the distribution of SNPs in the RANTES and CCR5 promoters and the association between these SNPs and HIV-1 disease progression in HIV-infected Koreans. Twenty-seven long-term non-progressors (LTNPs), 29 AIDS patients and 39 HIV-uninfected persons were enrolled in this study. SNPs for the RANTES and CCR5 promoters were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and a direct sequencing method. In the analysis of RANTES promoter polymorphisms, the genotypic and allelic frequencies of the RANTES -28G mutation were significantly lower in HIV-infected patients than in HIV-uninfected persons (P = 0.005 and P = 0.001, respectively). The genotypic frequencies of RANTES -28G and -403A mutations did not differ significantly between LTNPs and AIDS patients. The frequencies of three CCR5 promoter polymorphisms, designated 59029 G/A, 59353T/C, and 59402G/A, did not differ significantly between HIV-uninfected and HIV-infected patients. However, the allelic frequency of CCR559353C was significantly higher in AIDS patients than in LTNPs (P = 0.003). These results suggest that RANTES-28G and CCR5 59353C mutations might be associated with HIV infection or pathogenesis in the Korean population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18218038     DOI: 10.1111/j.1744-313X.2007.00743.x

Source DB:  PubMed          Journal:  Int J Immunogenet        ISSN: 1744-3121            Impact factor:   1.466


  9 in total

1.  A haplotype in the CCR5 gene promoter was associated with the susceptibility to HIV-1 infection in a northern Chinese population.

Authors:  Lidan Xu; Yuandong Qiao; Xuelong Zhang; Haiming Sun; Jingwei Wang; Donglin Sun; Xueyuan Jia; Chao Shen; Yanling Zhao; Yan Jin; Yang Yu; Hong Ling; Kaili Wang; Songbin Fu
Journal:  Mol Biol Rep       Date:  2010-04-04       Impact factor: 2.316

2.  Impact of CCR2 and SDF1 polymorphisms on disease progression in HIV-infected subjects in Thailand.

Authors:  Palanee Ammaranond; Sayompoo Sanguansitthianan; Poonlaph Phaengchomduan; Chanachai Sae-Lee; Sirimarn Mardkhumchan
Journal:  J Clin Lab Anal       Date:  2013-01       Impact factor: 2.352

3.  Influence of CCR5 and CCR2 genetic variants in the resistance/susceptibility to HIV in serodiscordant couples from Colombia.

Authors:  Wildeman Zapata; Wbeimar Aguilar-Jiménez; Nicolás Pineda-Trujillo; Winston Rojas; Hernando Estrada; María T Rugeles
Journal:  AIDS Res Hum Retroviruses       Date:  2013-11-09       Impact factor: 2.205

4.  Distribution of CCR5-Delta32, CCR5 promoter 59029 A/G, CCR2-64I and SDF1-3'A genetic polymorphisms in HIV-1 infected and uninfected patients in the west region of Cameroon.

Authors:  Céline Nguefeu Nkenfou; Linda Chapdeleine Mouafo Mekue; Christelle Tafou Nana; Jules Roger Kuiate
Journal:  BMC Res Notes       Date:  2013-07-23

Review 5.  Host Factors and HIV-1 Replication: Clinical Evidence and Potential Therapeutic Approaches.

Authors:  Mariana Santa-Marta; Paula Matos de Brito; Ana Godinho-Santos; Joao Goncalves
Journal:  Front Immunol       Date:  2013-10-24       Impact factor: 7.561

6.  Association between chemotactic chemokine ligand 5 -403G/A polymorphism and risk of human immunodeficiency virus-1 infection: a meta-analysis.

Authors:  Jianglong He; Xiaoquan Li; Jialin Tang; Tinli Jin; Qinghua Liao; Guoliang Hu
Journal:  Onco Targets Ther       Date:  2015-04-07       Impact factor: 4.147

7.  Association between regulated upon activation, normal T cells expressed and secreted (RANTES) -28C/G polymorphism and susceptibility to HIV-1 infection: a meta-analysis.

Authors:  Zhenghua Gong; Jialin Tang; Tianxin Xiang; Lunli Zhang; Qinghua Liao; Wei Liu; Yalin Wang
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

Review 8.  Metabolomics as an Approach to Characterise the Contrasting Roles of CCR5 in the Presence and Absence of Disease.

Authors:  Anandi Rautenbach; Aurelia A Williams
Journal:  Int J Mol Sci       Date:  2020-02-21       Impact factor: 5.923

9.  Effect of Combined Antiretroviral Therapy on the Levels of Selected Parameters Reflecting Metabolic and Inflammatory Disturbances in HIV-Infected Patients.

Authors:  Karolina Jurkowska; Beata Szymańska; Brygida Knysz; Agnieszka Piwowar
Journal:  J Clin Med       Date:  2022-03-19       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.